This expert-led webinar explores how ex-US clinical trials can help biotech and mid-size pharma companies accelerate development timelines, reduce operational risk, and build investor confidence. Gain insight into why certain regions offer strategic advantages, from regulatory flexibility to faster enrollment, and how to effectively integrate them into your development strategy.
Speakers include leaders from Molecule to Medicine, ARENSIA, Emeritus Research, and Novotech, offering a multi-perspective discussion moderated by Novotech’s VP of Drug Development Consulting.
Ideal for CEOs, CMOs, and clinical development leaders looking to optimize global trial strategies.